These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 18035805)

  • 1. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
    Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
    Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
    Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
    J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.
    Sharif A; Aghakhani A; Velayati AA; Banifazl M; Sharif MR; Razeghi E; Kheirkhah D; Kazemimanesh M; Bavand A; Ramezani A
    Intervirology; 2016; 59(3):179-185. PubMed ID: 28142135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.
    Azadmanesh K; Mohraz M; Kazemimanesh M; Aghakhani A; Foroughi M; Banifazl M; Eslamifar A; Ramezani A
    J Med Virol; 2015 Jul; 87(7):1124-9. PubMed ID: 25771750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
    Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
    J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
    Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
    J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
    Kishore J; Mukhopadhyay C
    Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
    Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
    J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
    Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
    J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
    Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
    J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
    Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
    J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
    van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
    Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
    Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
    Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
    Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
    Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.